1. Home
  2. Mesoblast

Tags : Mesoblast

PharmaShots Weekly Snapshot (Nov 16-20, 2020)

PharmaShots Weekly Snapshot (Nov 16-20, 2020)

Tuba Khan November 20, 2020

Eli Lilly and Incyte Receive FDA’s EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19 Published: Nov 20,2020 | Tags: baricitinib, COVID-19, Eli Lilly, Emergency Use Authorization, FDA’s, Incyte, receives, Remdesivir Novartis Signs a License Agreement with Mesoblast to Develop and Commercialize Remestemcel-L for ARDS Published: Nov 20,2020 | Tags: Agreement, ARDS, Commercialize, […]Read More

Novartis Signs a License Agreement with Mesoblast to Develop and Commercialize Remestemcel-L for ARDS

Novartis Signs a License Agreement with Mesoblast to Develop and

Tuba Khan November 20, 2020

Shots: Mesoblast to receive $25M up front and $25M as equity investment with additional payments and royalties on achievement of development, regulatory and commercial milestones Novartis to acquire the exclusive WW rights to develop, commercialize & manufacture remestemcel-L for ARDS & access to a cell-therapy based platform with WW rights to a range of potential […]Read More

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

Tuba Khan June 30, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Tuba Khan May 29, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

Copyright ©2020 PharmaShots | Powered by Octavus Consulting